NEW DELHI -- India is stepping up defenses against a possible third wave of coronavirus infections caused by omicron by implementing a slew of measures, including approving two more vaccines as well as Merck's COVID-19 pill, and expanding its inoculation drive to those aged 15 to 18.
India's Minister of Health Mansukh Mandaviya tweeted on Tuesday that the country "has given 3 approvals in a single day" for the Corbevax and Covovax vaccines, and antiviral drug molnupiravir for restricted use.
